Bridgefront Capital’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.39M Buy
5,513
+4,121
+296% +$1.25M 0.63% 18
2026
Q1
$297K Sell
1,392
-634
-31% -$142K 0.07% 394
2025
Q4
$347K Sell
2,026
-30,921
-94% -$4.81M 0.09% 345
2025
Q3
$4.41M Buy
32,947
+19,419
+144% +$2.06M 1.3% 1
2025
Q2
$1.32M Buy
13,528
+4,850
+56% +$385K 0.35% 56
2025
Q1
$631K Buy
8,678
+4,644
+115% +$366K 0.18% 188
2024
Q4
$291K Buy
+4,034
New +$306K 0.1% 369

Other funds holding LRCX

Bridgefront Capital's LRCX Position: Q2 2026 in Review

Bridgefront Capital increased its Lam Research (LRCX) stake by 296% in Q2 2026, buying an estimated $1.25M and bringing the position to 5,513 shares worth $2.39M. The position accounts for 0.63% of the portfolio, ranked #18.

Bridgefront Capital first reported a position in LRCX in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.41M in Q3 2025. 3,130 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Bridgefront Capital held 5,513 shares of Lam Research worth $2.39M as of Q2 2026.
  • Bridgefront Capital bought 4,121 Lam Research shares in Q2 2026, an estimated $1.25M.
  • Lam Research made up 0.63% of Bridgefront Capital's portfolio in Q2 2026, its #18 holding.
  • Bridgefront Capital first reported a position in Lam Research in Q4 2024 and has held it in 7 quarters since.
  • Bridgefront Capital's Lam Research position peaked at $4.41M in Q3 2025.
  • 3,130 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.